1.腫瘤化療聯(lián)合粒細(xì)胞-巨噬細(xì)胞刺激因子的輔助治療,，吳塵軒,，癌癥進(jìn)展,2012.10 (2):111-116.
2.Chenxuan Wu, Hongxing Guo, Yijun Wang, Yingtang Gao, Zhengyan Zhu, Zhi Du.
Extracellular domain of human 4-1BBL enhanced the function of cytotoxic
T-lymphocyte induced by dendritic cell.Cellular Immunology, 2011,271(1): 118- 123.
3.Chen-Xuan Wu, Qi Zou, Zheng-Yan Zhu, Ying-Tang Gao, Yi-Jun Wang. Intrahepatic transplantation of hepatic
oval cells for fulminant hepatic
failure in rats.World J Gastroenterol. 2009 March 28; 15(12): 1506-1511.
4.磷脂酰肌醇蛋白聚糖3在肝細(xì)胞肝癌中的表達(dá)及意義，郭洪生,，中國(guó)腫瘤臨床,，2009.08
5.經(jīng)鼻腸管腸內(nèi)營(yíng)養(yǎng)膳食治療胃癱，郭洪生,，天津醫(yī)藥,，2006.05
6.崔學(xué)振,尚培中.肝外膽管癌患者癌組織與血清中PLK1、Aurora A水平的變化及其臨床意義[J].中國(guó)普通外科雜志,2016,25(08):1151-1157.
7.王鐵山,崔學(xué)振.橋本氏甲狀腺炎合并原發(fā)性甲狀腺淋巴瘤[J].中國(guó)現(xiàn)代普通外科進(jìn)展,2017,20(12):1003-1005.
8.Xiang J; Jiang M; Du X,，The role of Hippo pathway in ferroptosis,
Frontiers in Oncology, 2023,；
9.Jiang M; Zhang W; Zhang R; Liu P; Ye Y; Yu W; Guo X; Yu J，
Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer, Oncogene, 2020,；
10.Jiang M; Chen J; Zhang W; Zhang R; Ye Y; Liu P; Yu W; Wei F; Ren X; Yu J,，
Interleukin-6 Transsignaling Pathway Promotes Immunosuppressive Myeloid Derived Suppressor
Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer, Front Immunol, 2017；
11.Jiang M; Zhang W; Liu P; Yu W; Liu T; Yu J,，Dysregulation of SOCS-Mediated negative
Feedback of Cytokine Signaling in Carcinogenesis
and its Significance in Cancer Treatment, Front Immunol, 2017,。
12.Song Yawen*; Sun Hui*; Wu Kailiang; Lyu Jianke; Zhang Jingyue; Gu Feng;
Ma Yongjie; Shen Beibei; Wang Chijuan; Chen Xiaojiao; Xu Jing; Li Weidong;
Liu Fangfang; Fu Li; SLex expression ininvasive micropapillary breast carcinoma is associated
with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator,
Cancer Biology and Medicine, 2021, 18(2): 477-489.（IF=5.347）
13.Zhong Benfu; Jiang Dewei; Hong Yang; Li Lifang; Qiu Li; Yang Ronghui; Jin Xiaohan; Song Yawen;
Chen Ceshi; Li Binghui;Glucose-6-phosphate dehydrogenase neutralizes stresses by supporting
reductive glutamine metabolism and AMPK activation,
Signal Transduction and Targeted Therapy,2021, 6(3): 580-583.（IF=38.104）
14.Jingyue Zhang; Yawen Song; Qianqian Shi; Li Fu; Research progress on FASN and
MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor
invasion and metastasis, Frontiers of Medicine, 2021, 15(5): 649-656. （IF=9.927）
15.宋雅文; 劉芳芳; 付麗;黏蛋白1/上皮細(xì)胞膜抗原及sLex在腫瘤轉(zhuǎn)移中的作用及相互關(guān)系的研究進(jìn)展, 中華病理學(xué)雜志, 2018, 47(11): 891-893.
16.The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary
breast cancer families.Dong L, Zhang H. Cancer Biol Med. 2021 Sep 28:j.issn.2095-3941.2021.0011.
Epub ahead of print. PMID: 34570441.
17.Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with
different molecular subtypes of breast cancer. Zhao J, Zhang H. Cancer Biol Med. 2020 Nov 15;17(4):
1014-1025. Epub 2020 Dec 15. PMID: 33299650; PMCID: PMC7721095.
18.副乳腺癌37例臨床診治分析[J].中華普通外科雜志,2019,34(1):27-30. 張海蓮，李會(huì)江,，趙晶,，張世超，趙楊,，劉俊田.
19.乳腺癌家系遺傳易感基因研究進(jìn)展[J].中國(guó)腫瘤臨床,2018,45(21):1113-1116. 張海蓮,，張世超，于津浦,，劉俊田.
|
